| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=0.1uM, [4-(2-Acetylamino-2-{1-[2-carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-cyclohexylcarbamoyl}-ethyl)-benzyl]-phosphonic acid, Grb2 SH2 Domain Inhibitors targeting GRB2, PTK2B, PTK2, PTK6, PTK7 (Novartis, 10699955) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/10699955 |
| Similar Terms | |
| Downloads & Tools |
4 genes differentially expressed following the CB-82-BV25_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| RPS10 | ribosomal protein S10 | 0.220705 |
| RPS29 | ribosomal protein S29 | 0.203003 |
| MGST2 | microsomal glutathione S-transferase 2 | 0.203003 |
| Symbol | Name | Standardized Value |
|---|---|---|
| ACTN4 | actinin, alpha 4 | -0.217385 |